alpha-Dihydroartemisinin CAS#81496-81-3

  • Potent Antimalarial Efficacy: Exhibits robust activity against asexual-stage Plasmodium parasites, including strains of Plasmodium falciparum resistant to chloroquine and piperaquine.

  • Rapid Oral Bioavailability: Demonstrates exceptional gastrointestinal absorption, achieving peak plasma concentrations within 1.33 hours following oral administration.

  • Broad Clinical Indication: Deployed for the management of all clinical forms of malaria, particularly in medical emergencies such as cerebral malaria and severe drug-resistant infections.

  • Favorable Toxicological Profile: Displays an encouraging safety profile, with animal reproductive studies revealing no evidence of teratogenic effects even when administered during gestation.

WhatsApp
Product Details

Dihydroartemisinin displays robust pharmacological activity against asexual-stage Plasmodium parasites, successfully suppressing clinical symptoms and eradicating diverse Plasmodium strains throughout their asexual reproductive cycle. Furthermore, it demonstrates substantial therapeutic efficacy against both chloroquine- and piperaquine-resistant strains of Plasmodium falciparum while preserving an encouraging safety profile. Although animal investigations indicate that administration during gestation in murine models may elevate the incidence of fetal variations, no overt teratogenic malformations have been observed.

 alpha-Dihydroartemisinin CAS# 81496-81-3

Exhibiting exceptional oral bioavailability, this compound attains peak plasma concentrations ($C_{\text{max}}$) of $0.71\,\mu\text{g/mL}$ at $1.33$ hours ($t_{\text{max}}$) following an oral administration of $2\,\text{mg/kg}$. From a clinical perspective, it is utilized for the treatment of all clinical manifestations of malaria, holding particular significance in the emergency management of cerebral malaria as well as severe cases of chloroquine- and piperaquine-resistant Plasmodium falciparum infections.

alpha-Dihydroartemisinin CAS# 81496-81-3

Parameters

Melting point 142-144°C
Boiling point 375.6±42.0 °C(Predicted)
density 1.24±0.1 g/cm3(Predicted)
storage temp. 2-8°C
solubility Chloroform (Slightly), DMSO (Slightly), Ethyl Acetate (Slightly), Methanol (Slightly)
form Solid
pka12.61±0.70(Predicted)
color White to Off-White

Safety Information

alpha-Dihydroartemisinin Usage And Synthesis 
Chemical PropertiesWhite needle like crystal
Usesantimalarial, antiinflammatory
DefinitionChEBI: Dihydroartemisinin (DHA) is an artemisinin derivative.
targetAntifection

alpha-Dihydroartemisinin CAS# 81496-81-3

WhatsApp